Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

PharmaVOICE image

News from PharmaVOICE

Your destination for news from PharmaVOICE. See how PharmaVOICE’s media bias impacts the breaking news stories of today.

In total, 72 have been published by PharmaVOICE which Ground News has aggregated in the past 3 months.

The Ground News media bias check for PharmaVOICE is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

PharmaVOICE’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about PharmaVOICE

Where is PharmaVOICE located?PharmaVOICE's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top PharmaVOICE News

FDA Says It's Investigating Sarepta’s Duchenne Patient Deaths

United States · United States

FDA Says It's Investigating Sarepta’s Duchenne Patient Deaths

83% Center coverage: 12 sources

(MedPage Today) -- The FDA is investigating the deaths of two boys with Duchenne muscular dystrophy who died soon after being treated with delandistrogene moxeparvovec (Elevidys) gene therapy, the agency said. The investigation will focus on the...See the Story

PATIENTS Program Layoffs Announced Amid NIH Grant Cuts

Science · United States

PATIENTS Program Layoffs Announced Amid NIH Grant Cuts

67% Center coverage: 3 sources

Empty offices and desks within the University of Maryland School of Pharmacy serve as visible evidence of the impact of cuts to federal research grants.See the Story

Can China Sustain a Surge in Oncology Drug Innovation?

Medical · China

Can China Sustain a Surge in Oncology Drug Innovation?

Coverage: 2 sources

The country’s trajectory may get a boost from anticipated results of a Keytruda rival’s U.S. trials.See the Story

AI’s ‘massive transition’ in biopharma shapes leadership mindsets — tension and all

100% Center coverage: 1 sources

The AI revolution is driving tension between new technology and the traditional approaches in drugmaking. Biopharma leaders are trying to navigate those turbulent waters.Artificial Intelligence Read Article

FDA’s new mission to speed drug reviews

100% Center coverage: 1 sources

FDA Commissioner Dr. Marty Makary is leading a handful of controversial new initiatives to make the drug review process more streamlined.FDA · Rockville Read Article

3 of the year’s most notable FDA nods

100% Center coverage: 1 sources

The agency has granted approvals steadily in the first part of the year, including nods for several breakthrough therapies.Washington DC · Washington Read Article

How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’

100% Center coverage: 1 sources

J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.Pharma · United States Read Article

Biogen scores Cannes Festival win with dark humored campaign

100% Center coverage: 1 sources

The company’s unique campaign for a rare, terminal illness nabbed millions of views and a spot on the main stage at the Cannes Lions Festival of Creativity.Cannes Film Festival · Cannes Read Article

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

100% Center coverage: 1 sources

More drugs surpassed $10 billion in revenue last year than ever before.Read Article

Biotech’s Turning Point: for Every Challenge, an Opportunity in Disguise

100% Center coverage: 1 sources

As hurdles litter biotech’s future, forward-thinking leaders look for ways to leap to the other side.Biotech · United States See the Story

FDA to offer faster drug reviews to companies promoting ‘national priorities’

66% Center coverage: 63 sources

FDA · United States See the Story

Breaking News Topics Related to PharmaVOICE